Duloxetine
Product Images NDC 53002-1561

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 53002-1561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Fig1

Duloxetine Fig1
This data appears to be a graph showing the time from randomization to relapse for patients with relapse who were treated with placebo versus Duloxetine. The x-axis measures time in days, ranging from 0 to approximately 250, and the y-axis measures the number of patients with relapse, ranging from 0.4 to 1.0. It is not possible to determine the context or significance of this information without additional information.*
FDA Label Image

Duloxetine Fig10

Duloxetine Fig10
This is a product description for a medication called Duloxetine which comes in 60/120mg dosage and is taken once daily. The text also contains a graph indicating the percent improvement in pain from baseline as an effect of the medication.*
FDA Label Image

Duloxetine Fig2

Duloxetine Fig2
The text describes a chart that shows the proportion of patients who relapsed during a certain period of time after being randomized in a treatment. The chart compares the relapse rate of a placebo treatment to a treatment using the drug Duloxetine. The horizontal axis shows the time in days from randomization to relapse, and the vertical axis displays the proportion of patients who relapsed. The chart shows a steady decrease in the proportion of patients who relapsed in the Duloxetine treatment compared to the placebo treatment over time.*
FDA Label Image

Duloxetine Fig3

Duloxetine Fig3
The text is a table with some column headings and values, and it's not possible to generate a useful description with only this information.*
FDA Label Image

Duloxetine Fig4

Duloxetine Fig4
Not available.*
FDA Label Image

Duloxetine Fig5

Duloxetine Fig5
This appears to be a graph or chart representing the percentage of patients who improved on medication. The medication options are Dulozetine 60mg taken twice daily, Duloxetine 60mg taken once daily, and a placebo. The chart also displays the percentage improvement in pain from baseline.*
FDA Label Image

Duloxetine Fig6

FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
This is a clinical prescription consisting of Placebo and Duloxetine 60/120 mg to be taken once daily. No further information or context is available.*
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
This is a description of a study that compares the effectiveness of Placebo and Duloxetine 60 mg taken once daily in treating pain, with the graph showing the percentage of pain improvement from baseline over time.*
FDA Label Image

Duloxetine-structure (Duloxetine Structure)

FDA Label Image

Label Image (Lbl530021494)

Label Image (Lbl530021494)
This appears to be a product label for "DULOHETNE 300G" capsules. The recommended dosage is to take one capsule daily, or as directed by instructions.*
FDA Label Image

Label Image (Lbl530021561)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.